Inhibitors of Akt activity

Details Inhibitors of Akt activity Inhibitors of Akt activity

2008-07-08

2008-07-08

Bernhardt, Emily (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S353000, C544S350000

Reexamination Certificate

active

11705677

ABSTRACT:
The present invention is directed to compounds comprising a 2,3-diphenylquinoxaline moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention

REFERENCES:
patent: 5932580 (1999-08-01), Levitzki et al.
patent: 5972937 (1999-10-01), Gaster et al.
patent: 6060491 (2000-05-01), Pruitt et al.
patent: 2002/0127214 (2002-09-01), Hemmings
patent: 2006/0142178 (2006-06-01), Barnett et al.
patent: WO 96/23783 (1996-08-01), None
patent: WO 97/22360 (1997-06-01), None
patent: WO 99/42461 (1999-06-01), None
patent: WO 01/91754 (2001-12-01), None
patent: WO 02/083138 (2002-10-01), None
patent: WO 03/084473 (2003-10-01), None
Nakatani, et al., J. Bio. Chem., vol. 274, pp. 21528-21535 (1999).
Bellacosa, et al., Intl. J. Cancer, vol. 64, pp. 280-285 (1995).
Hanada, et al., Biochimica et Biophysica Acta, vol. 1697, pp. 3-16 (2004).

Affiliated with

Also associated with

Rating

Inhibitors of Akt activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of Akt activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of Akt activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3927597